Title : Parameters of the tissue factor pathway with coumadin/dipyridamole versus ticlopidine as adjunct antithrombotic-drug regimen in coronary artery stenting.

Pub. Date : 2003 Jun

PMID : 12945880






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 These data suggest reduced release of circulating TF by combined anti-platelet therapy with ticlopidine and aspirin after coronary artery stenting, which may-contribute to the lower incidence of subacute stent thrombosis previously observed. Aspirin coagulation factor III, tissue factor Homo sapiens